Market-View-Feature-Image

View on market: Stay Cautious, be with quality business:

U.S. futures and bonds fell amid rising inflation, monetary tightening and fears of global economic slowdown. Stocks in Japan led the decline in Asian markets while China has issued warnings about the jobs outlook as the country tightens curbs to prevent to spread of Covid-19. The Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50, fell over 1.2% to 16,215.50 points as of 6:45 a.m. Oil slipped from near $100 per barrel amid rising supply risks. Elsewhere, bitcoin hovered around $34,100.

LIC-IPO-ELITE-WEALTH-LIMITED.

Economic Calendar:

  • INR: Trade balance on 13thMay
  • INR: CPI Inflation on 12th May 2022.
  • USD: Crude Oil Inventories 11th May, 2022.
  • USD: Core CPI 11th May, 2022.

Earnings Today: UPL, Dalmia Bharat, Vedant Fashions, Central Bank of India, Suven Pharmaceuticals, Gujarat Narmada Valley Fertilizers & Chemicals, PVR, KEI Industries, Godrej Agrovet, BASF India, Mold-Tek Packaging, Craftsman Automation, Infibeam Avenues, Cosmo Films, CMS Info System, Borosil, Aarti Drugs

Q4Fy22 Earning:

Reliance Industries: Revenue up 10.78% at Rs 2,07,375 crore (less excise duty) Vs Rs 1,85,027 crore (Bloomberg Estimate: Rs 2,14,942.6 crore) EBITDA up 5.59% at Rs 31,366 crore Vs Rs 29,706 crore (Bloomberg Estimate: Rs 31,445.5 crore) EBITDA margin 15.1% Vs 16.05% (Bloomberg Estimate: 16.9%) Net profit fell 12.65% at Rs 16,203 crore.

Tata Power: Revenue up 15.41% at Rs 11,959.96 crore Vs Rs 10,362.6 crore (Bloomberg Estimate: Rs 11,515.2 crore) EBITDA up 20.06% at Rs 1,868.59 crore Vs Rs 1,556.41 crore (Bloomberg Estimate: Rs 1,805.3 crore) EBITDA margin 15.62% Vs 15.02% (Bloomberg Estimate: 15.67%) Net profit up 28.04% at Rs 503.11 crore Vs Rs 392.94 crore.

Grindwell Norton Q4 FY22 (Consolidated, YoY) Revenue up 9.84% at Rs 558.87 crore Vs Rs 508.8 crore EBITDA up 9.42% at Rs 123.64 crore Vs Rs 113 crore EBITDA margin flat at 22% Net profit up 11.4% at Rs 89.72 crore Vs Rs 80.54 crore Recommended dividend of Rs 12 per share of face value of Rs 5 each.

Brokerage Radar:

CLSA ON TATA POWER: Sell, TP Rs 212 Coal disappoints again Indonesia coal: both volume & ASP down QoQ Weak 4Q pepped-up by tax break on CGPL merger Remains expensive at 24x FY24CL EPS War-led commodity spikes & a retail frenzy provide an exit opportunity.

GOLDMAN SACHS ON RELIANCE: Buy, TP Rs 3200 Refining led earnings acceleration to drive consensus upgrades 4Q EBITDA grew 6% QoQ, 7th qtr of sequential growth led by telecom & refining Expect further acceleration in earnings with expectation of 21% QoQ growth in 1QFY23 led by refining & E&P.

JP MORGAN ON RELIANCE: Neutral, TP Rs 2575 Strong operating qtr, should get better with Refining, E&P & Telecom; Capex remains sharply elevated Seasonally entering news flow heavy period around AGM & given surge in diesel cracks & refining margins

International Markets:

U.S. & Europe:

Particulars 06th May Chg Chg(%)
Nasdaq 12,144.66 -173.03 -1.4
Dow 32899.37 98.60 -0.30
FTSE 7,387.94 -115.33 -1.54
CAC 6,258.36 -110.04 -1.73
DAX 13,674.29 -228.23 -1.64
Dow Fut.* 32503.10 -396.10 -1.20

Asian markets:

Particulars 09th May Chg. Chg(%)
SGX Nifty 16,222.50 -197.5 -1.2
Nikkei 26,410.30 -593.26 -2.2
Straits Times 3,287.45 -4.44 -0.13
Hang Seng 20,001.96 -791.44 -3.81
Shanghai 3,008.35 6.79 0.23

ADR Watch:

Particulars 06th May Chg. Chg.(%)
Dr Reddy 50.86 -0.15 -0.29
HDFC Bank 52.04 -1.36 -2.55
ICICI Bank 18.51 -0.34 -1.8
Infosys 19.85 -0.46 -2.26
Tata Motor 26.53 -0.77 -2.82
Wipro 6.24 -0.1 -1.58

Commodities & Currency:

Particulars Current Price Chg(%)
USD/INR 76.92   0.87
Brent 112.52 0.13
Gold 1875.36  -0.41
Silver 22.299  -0.61

FIIs & DII:

Particulars 06th May                           05th May
FIIs -5517.08                                      -2074.74                                     
DIIs 3014.85 2229.31

News Update

Mindtree/ Larsen & Toubro Infotech: LTI board approves merger of Mindtree with company. The share exchange ratio is 73 shares of face value Re. 1 each of L&T Infotech for every 100 equity shares of Mindtree of face value Rs. 10.

Lupin: The company has received FDA approval for Pregabalin Capsules to market a generic equivalent of Lyrica capsules.

HCL Technologies: The has signed a definitive agreement for the acquisition of Confinale AG, a Switzerland-based digital banking and wealth management consulting specialist and Avaloq Premium Implementation partner.
Future Consumer: The company will sell its 18.58% stake in Amar Chitra Katha for Rs 13.62 crore.

Indostar Capital: The company flags off deviations from processes in commercial vehicle loan portfolio and may be required to make an additional estimated credit loss provisioning between Rs 557 crore to Rs 677 crore. Following the additional provisions, capital adequacy ratio of entity to reduce from 35.1% to 25%.

Surya Roshni: The company has received order of Rs 53.06 crore for supply of API- 5L Grade X 70 3LPE Coated pipes from GAIL (India).

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL